Publications by authors named "Dawn Matthews"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,781

Total Likes

440

Extended Reach

2,828,739

Social Features

110
M
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.
Lisa Mosconi, Valentina Berti, Jonathan Dyke, Eva Schelbaum, Steven Jett, Lacey Loughlin, Grace Jang, Aneela Rahman, Hollie Hristov, Silky Pahlajani

Sci Rep· June 2021

Videos about Article: user user

2 4 99 23 4 8

View All Article and Social Media Activity
S
Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
Aneela Rahman, Eva Schelbaum, Katherine Hoffman, Ivan Diaz, Hollie Hristov, Randolph Andrews, Steven Jett, Hande Jackson, Andrea Lee, Harini Sarva

Neurology· July 2020

Videos about Article: user

1 2 8 3 30

View All Article and Social Media Activity
E
EC images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studies.
Alaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, Mark Slifstein, Erik Mannaert, Dawn C Matthews

J Cereb Blood Flow Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression.
Matilde Nerattini, Valentina Berti, Dawn C Matthews, Schantel Williams, Caroline Andy

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.
Matilde Nerattini, Schantel Williams, Caroline Andy, Caroline Carlton, Camila Zarate, Dawn C Matthews

PLoS One· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining the Evidence for In Vivo Brain Estrogen Receptor Density by Neuroendocrine Aging and Relationships with Cognition and Symptomatology.
Lisa Mosconi, Matilde Nerattini, Valentina Berti, Dawn C Matthews, Caroline Andy

J Nucl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving event prediction using general practitioner clinical judgement in a digital risk stratification model: a pilot study.
Emma Parry, Kamran Ahmed, Elizabeth Guest, Vijay Klaire, Abdool Koodaruth, Dawn Matthews

BMC Med Inform Decis Mak· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.
Dawn C Matthews, Jefferson W Kinney, Aaron Ritter, Randolph D Andrews, Erin N Toledano Strom

Alzheimers Dement (N Y)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology.
Lisa Mosconi, Matilde Nerattini, Dawn C Matthews, Steven Jett, Caroline Andy

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GP assessment of unmet need in a complex multimorbid population using a data-driven and clinical triage system: a prospective cohort study.
Emma Parry, Kamran Ahmed, Simon Evans, Elizabeth Guest, Vijay Klaire, Dawn Matthews

BJGP Open· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital health and inpatient palliative care: a cohort-controlled study.
Baldev Malkit Singh, Nisha Kumari-Dewat, Adam Ryder, Emma Parry, Vijay Klaire, Dawn Matthews

BMJ Support Palliat Care· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification.
Anne M Smith, Nancy A Obuchowski, Norman L Foster, Gregory Klein, P David Mozley, Dawn Matthews

J Nucl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical Symptomatology.
Lisa Mosconi, Steven Jett, Matilde Nerattini, Caroline Andy, Camila Boneu Yepez, Dawn Matthews

Res Sq· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, Miles N Wernick, Stephen C Strother

Alzheimers Dement (N Y)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
Stéphane Epelbaum, Ninon Burgos, Michael Canney, Dawn Matthews, Marion Houot

Alzheimers Res Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.
Adam C Raikes, Gerson D Hernandez, Dawn C Matthews, Ana S Lukic, Meng Law

Alzheimers Dement (N Y)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Dawn C Matthews, Xiangling Mao, Kathleen Dowd, Diamanto Tsakanikas, Caroline S Jiang

Brain· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value-Generating Exploratory Trials in Neurodegenerative Dementias.
Lauren G Friedman, Nicholas McKeehan, Yuko Hara, Jeffrey L Cummings, Dawn C Matthews

Neurology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia.
Dawn C Matthews, Aaron Ritter, Ronald G Thomas, Randolph D Andrews, Ana S Lukic

Alzheimers Dement (N Y)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.
Gerson D Hernandez, Christine M Solinsky, Wendy J Mack, Naoko Kono, Kathleen E Rodgers, Dawn Matthews

Alzheimers Dement (N Y)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
Michael S Rafii, Michael C Donohue, Dawn C Matthews, Gabriela Muranevici, Seth Ness

J Alzheimers Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, Maria Tome, Spiros Vamvakas, Dawn Matthews

J Parkinsons Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical Considerations for Planning Clinical Trials with Quantitative Imaging Biomarkers.
Nancy A Obuchowski, P David Mozley, Dawn Matthews, Andrew Buckler, Jennifer Bullen

J Natl Cancer Inst· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, Maria Tome, Spiros Vamvakas, Dawn Matthews

J Parkinsons Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis